卵巢癌是女性生殖系统的常见恶性肿瘤之一,由于卵巢解剖部位独特、早期多无明显症状,且临床上缺乏有效的早期诊断方法,因而卵巢癌被发现时多已属于晚期(Ⅲ期、Ⅳ期),失去了手术彻底切除的时机而不得不依赖于化学药物维持治疗[1]。目前,临床上多将紫杉醇与铂类化疗药物作为卵巢癌化疗的首选方案[2],本文就近年来我院应用紫杉醇联合卡铂(TC)方案与吉西他滨联合顺铂(GP)方案治疗晚期上皮性卵巢癌的临床疗效及毒性作用进行分析比较报告如下。1资料与方法 Ovarian cancer is one of the common malignant tumors of the female reproductive system. Due to the unique anatomy of the ovary and early symptoms, and the lack of effective early diagnosis clinically, ovarian cancer is mostly late stage (stage III, IV Period), has lost the opportunity for radical resection and had to rely on the maintenance of chemical drugs [1]. At present, the clinical paclitaxel and platinum-based chemotherapy as the first choice of chemotherapy for ovarian cancer [2], this article in recent years, our hospital with paclitaxel combined carboplatin (TC) and gemcitabine combined with cisplatin (GP) regimen for advanced epithelial The clinical efficacy and toxicity of ovarian cancer analysis and comparison report is as follows. 1 data and methods